Articles with public access mandates - David Harold DrewryLearn more
Not available anywhere: 8
Review
Design of a cyclin G associated kinase (GAK)/epidermal growth factor receptor (EGFR) inhibitor set to interrogate the relationship of EGFR and GAK in chordoma
CRM Asquith, KM Naegeli, MP East, T Laitinen, TM Havener, CI Wells, ...
Journal of Medicinal Chemistry 62 (9), 4772-4778, 2019
Mandates: Genome Canada, Wellcome Trust
Review
Drug discovery and development for schistosomiasis
CR Caffrey, N El‐Sakkary, P Mäder, R Krieg, K Becker, M Schlitzer, ...
Neglected tropical diseases: drug discovery and development, 187-225, 2019
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Review
CDK16: the pick of the understudied PCTAIRE kinases
A Axtman, D Drewry, C Wells
Nature Reviews Drug Discovery 18 (7), 489-490, 2019
Mandates: US National Institutes of Health
Review
NUAK family kinase 2 is a novel therapeutic target for prostate cancer
W Fu, MT Zhao, LM Driver, AU Schirmer, Q Yin, S You, SJ Freedland, ...
Molecular Carcinogenesis 61 (3), 334-345, 2022
Mandates: US Department of Defense, US National Institutes of Health
Review
Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase
N Russ, M Schröder, BT Berger, S Mandel, Y Aydogan, S Mauer, C Pohl, ...
Journal of medicinal chemistry 64 (19), 14358-14376, 2021
Mandates: Genome Canada, Wellcome Trust
Review
Targeting never-in-mitosis-A related kinase 5 in cancer: a review
MD Matossian, CI Wells, WJ Zuercher, BM Collins-Burow, DH Drewry, ...
Current Medicinal Chemistry 28 (30), 6096-6109, 2021
Mandates: US National Institutes of Health, Genome Canada, Wellcome Trust
Review
Developing a Kinase Chemogenomic Set: Facilitating Investigation into Kinase Biology by Linking Phenotypes to Targets
CI Wells, DH Drewry
Chemogenomics: Methods and Protocols, 11-24, 2023
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo, Genome Canada …
Review
A Transcription-uncoupled Negative Feedback Loop for the 1 WNT Pathway: WNT Activates the AAK1 Kinase to Promote Clathrin-mediated Endocytosis of LRP6
MJ Agajanian, MP Walker, AD Axtman, RR Ruela-de-Sousa, ...
Mandates: US National Institutes of Health, Genome Canada, Cancer Research UK …
Available somewhere: 101
Review
Comprehensive characterization of the published kinase inhibitor set
JM Elkins, V Fedele, M Szklarz, KR Abdul Azeez, E Salah, J Mikolajczyk, ...
Nature biotechnology 34 (1), 95-103, 2016
Mandates: Genome Canada, British Heart Foundation, Wellcome Trust
Review
New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource
I Pena, M Pilar Manzano, J Cantizani, A Kessler, J Alonso-Padilla, ...
Scientific reports 5 (1), 8771, 2015
Mandates: Wellcome Trust
Review
Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition
NH Theodoulou, P Bamborough, AJ Bannister, I Becher, RA Bit, KH Che, ...
Journal of medicinal chemistry 59 (4), 1425-1439, 2016
Mandates: UK Engineering and Physical Sciences Research Council, Wellcome Trust
Review
Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement
JD Vasta, CR Corona, J Wilkinson, CA Zimprich, JR Hartnett, MR Ingold, ...
Cell chemical biology 25 (2), 206-214. e11, 2018
Mandates: US National Institutes of Health, Genome Canada, Wellcome Trust
Review
A public-private partnership to unlock the untargeted kinome
S Knapp, P Arruda, J Blagg, S Burley, DH Drewry, A Edwards, D Fabbro, ...
Nature chemical biology 9 (1), 3-6, 2013
Mandates: Cancer Research UK
Review
Discovery and characterization of GSK2801, a selective chemical probe for the bromodomains BAZ2A and BAZ2B
P Chen, A Chaikuad, P Bamborough, M Bantscheff, C Bountra, C Chung, ...
Journal of medicinal chemistry 59 (4), 1410-1424, 2016
Mandates: Genome Canada, Wellcome Trust
Review
Progress towards a public chemogenomic set for protein kinases and a call for contributions
DH Drewry, CI Wells, DM Andrews, R Angell, H Al-Ali, AD Axtman, ...
PloS one 12 (8), e0181585, 2017
Mandates: US National Institutes of Health, Genome Canada, Wellcome Trust
Review
Donated chemical probes for open science
S Müller, S Ackloo, CH Arrowsmith, M Bauser, JL Baryza, J Blagg, ...
elife 7, e34311, 2018
Mandates: Genome Canada, German Research Foundation, Cancer Research UK, Wellcome Trust
Review
CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
L Racioppi, ER Nelson, W Huang, D Mukherjee, SA Lawrence, W Lento, ...
Nature Communications 10 (1), 2450, 2019
Mandates: US Department of Defense, US National Institutes of Health, Susan G. Komen
Review
Quantifying CDK inhibitor selectivity in live cells
CI Wells, JD Vasta, CR Corona, J Wilkinson, CA Zimprich, MR Ingold, ...
Nature communications 11 (1), 2743, 2020
Mandates: US National Institutes of Health, Genome Canada, Wellcome Trust
Review
The kinase chemogenomic set (KCGS): an open science resource for kinase vulnerability identification
CI Wells, H Al-Ali, DM Andrews, CRM Asquith, AD Axtman, I Dikic, ...
International journal of molecular sciences 22 (2), 566, 2021
Mandates: US National Institutes of Health, Genome Canada, German Research Foundation …
Review
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone, M Jorgensen, DH Drewry, WJ Zuercher, ...
The Journal of pathology 239 (3), 320-334, 2016
Mandates: Austrian Science Fund, Cancer Research UK, National Institute for Health …
Publication and funding information is determined automatically by a computer program